Founded with a mission to revolutionize tendon and ligament reconstruction, Artelon is a medical technology company that specializes in the development of bio-textiles. Their core vision focuses on enhancing patient mobility and stability through innovative synthetic materials. Artelon's primary product, FLEXBAND, is designed for the kinematic reinforcement of tendons and ligaments, aiming to restore both stability and motion. The company targets the orthopedic market, particularly focusing on patients requiring tissue reconstruction.
Artelon has garnered attention through its advanced bio-textile technology, attracting notable investors and medical professionals in the field. The company's achievements include successful clinical outcomes and widespread adoption of their FLEXBAND product in surgical procedures. Artelon's impact is evident in improved patient recovery times and enhanced quality of life for those undergoing tendon and ligament reconstruction.
